LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

EuropaBio comments on the public consultation on blue bioeconomy

10/08/2021
OTHER
EuropaBio comments on the public consultation on blue bioeconomy

August 2021

These comments complement our reply to the public consultation on blue bioeconomy and the development of a strong and sustainable EU algae sector. The algae sector includes both microalgae and macroalgae; our comments concentrate on microalgae use.

Industrial Biotechnology (IB) actively uses enzymes and micro-organisms (including algae) to make bio-based products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles, and bioenergy. Algae products have tremendous potential to address global challenges in food and feed production and health as well as support a transition to a bio-based economy. Furthermore, production systems for algae often have low environmental impact reducing the use of potable water, arable land, and fossil-based energy.

To explore the full potential of algae products it is important to ensure an enabling governance framework to establish trust and confidence amongst industry, investors, brands, and consumers. Europe needs industry support measures to develop the algae industry and bring new algae species to the market under the Novel Food Regulation (for example by identifying and sharing best practices or identifying species that do not require Novel Food authorization procedure). An additional aspect to consider is how the development of innovative approaches to improve the characteristics of algae (such as for example gene technology and new genomic techniques) can be supported, for instance through ensuring a proportionate regulatory framework as well as generating public trust and support for such developments.

The relatively new application of algae in food and feed will also require consumer awareness and acceptance to help ensure success of algae adoption and initiatives such as the EU Blue Growth Strategy. It is important to promote the availability of sustainable algae-based products such as biomaterials, textiles, cosmetics, biopolymers, biofuels, and fertilizers or biostimulants. Communications efforts around the nutritious, delicious, and sustainable attributes of algae ingredients should be launched. Accelerating consumer adoption is critical both in growing the industry and to help address EU ambitions linked to environment and consumer health.

Please see also:

Reduce the depletion of small fish in our oceans – EuropaBio Inspired By Life case study on algae-derived omega 3
What if we used algae to make biofuel? – EuropaBio factsheet

EuropaBio comments on the public consultation on blue bioeconomy


Download
Share
Communications Team
Communications Team

Related posts

14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more
03/07/2025

Life Sciences Strategy Embraces Biotech for Global Impact


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.